Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

A First-in-Human Phase I Study of CTX-712 in Patients with Advanced, Relapsed or Refractory Malignant Tumors - Hematologic Malignancies Dose Escalation Cohort

Hisayuki Yokoyama, Koji Ando, Noriko Fukuhara, Hiroatsu Iida, Suguru Fukuhara, Hiroshi Miyake, Yasushi Tanoue, Maki Yamamoto, Hirokazu Tozaki, Akio Mizutani, Daisuke Morishita, Kunihiko Takeyama, Toshio Shimizu, Noboru Yamamoto

Blood (2022) 140 (Supplement 1): 6211–6212.

https://doi.org/10.1182/blood-2022-157241

Published: 2022

Journal Articles

Caspase-3 controls AML1-ETO–driven leukemogenesis via autophagy modulation in a ULK1-dependent manner

Na Man, Yurong Tan, Xiao-Jian Sun, Fan Liu, Guoyan Cheng, Sarah M. Greenblatt, Camilo Martinez, Daniel L. Karl, Koji Ando, Ming Sun, Dan Hou, Bingyi Chen, Mingjiang Xu, Feng-Chun Yang, Zhu Chen, Saijuan Chen, Stephen D. Nimer, Lan Wang

Blood (2017) 129 (20): 2782–2792.

https://doi.org/10.1182/blood-2016-10-745034

Published: 2017

Includes: Supplemental data

Journal Articles

The AML-Associated FLT3-ITD Kinase Regulates Histone Modifications and Cytokine Signaling, Via Effects on PRMT5

Koji Ando, MD PhD, Pierre-Jacques Hamard, PhD, Fan Liu, PhD, Concepcion Martinez, Yuguang Ban, PhD, Xi Chen, PhD, Stephen D. Nimer, MD

Blood (2016) 128 (22): 2696.

https://doi.org/10.1182/blood.V128.22.2696.2696

Published: 2016

Journal Articles

Heat Shock Protein 90 Inhibitor NVP-AUY922 Has Potent Anti-Tumor Activity With Adult T-Cell Leukemia-Lymphoma Cells

Hiroaki Taniguchi, MD, Hiroo Hasegawa, MD, PhD, Daisuke Sasaki, PhD, Koji Ando, MD, PhD, Yasushi Sawayama, MD, PhD, Yoshitaka Imaizumi, MD, PhD, Daisuke Imanishi, MD, PhD, Jun Taguchi, MD, PhD, Tomoko Hata, MD, PhD, Kunihiro Tsukasaki, MD, PhD, Katsunori Yanagihara, MD, PhD, Naoki Mori, MD, PhD, Yasushi Miyazaki, MD, PhD

Blood (2013) 122 (21): 1829.

https://doi.org/10.1182/blood.V122.21.1829.1829

Published: 2013

Journal Articles

Treatment of relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: the Nagasaki Transplant Group experience

Hidehiro Itonaga, Hideki Tsushima, Jun Taguchi, Takuya Fukushima, Hiroaki Taniguchi, Shinya Sato, Koji Ando, Yasushi Sawayama, Emi Matsuo, Reishi Yamasaki, Yasuyuki Onimaru, Daisuke Imanishi, Yoshitaka Imaizumi, Shinichiro Yoshida, Tomoko Hata, Yukiyoshi Moriuchi, Naokuni Uike, Yasushi Miyazaki

Blood (2013) 121 (1): 219–225.

https://doi.org/10.1182/blood-2012-07-444372

Published: 2013

Journal Articles

Transcriptional Activity of MEF/ELF4 on the HDM2 Promoter Is Enhanced by the Mutation of the NPM1 Gene

Koji Ando, MD, Emi Matsuo, MD, PhD, Kensuke Horio, MD, Shinya Tominaga, MD, Daisuke Imanishi, MD, PhD, Yoshitaka Imaizumi, MD, PhD, Hideki Tsushima, MD, PhD, Masako Iwanaga, MD, PhD, MPH, Hitoshi Kiyoi, MD, PhD, Tomoki Naoe, MD, PhD, Yasushi Miyazaki, MD, PhD

Blood (2010) 116 (21): 179.

https://doi.org/10.1182/blood.V116.21.179.179

Published: 2010

Journal Articles

Expression of 67-Kda Laminin Receptor (67LR) Relates to the Aggressiveness and Poor Prognosis of AML: Modulation of the Expression of GM-CSF Receptor by 67LR.

Koji Ando, MD, Yasushi Miyazaki, Daisuke Imanishi, Masako Iwanaga, Hideki Tsushima, Jun Taguchi, Takuya Fukushima, Shinichiro Yoshida, Tomoko Hata, Masao Tomonaga, MD, PhD

Blood (2008) 112 (11): 926.

https://doi.org/10.1182/blood.V112.11.926.926

Published: 2008

Journal Articles

Expression of the 67-kDa Laminin Receptor Is Associated with Increased AML Cells through the Enhanced GM-CSF/Stat5 Signaling.

Koji Ando, MD, Yasushi Miyazaki, MD, Yasushi Sawayama, MD, Kensuke Horio, MD, Emi Matsuo, MD, Reishi Yamasaki, MD, Yoriko Inoue, MD, Masako Iwanaga, MD, Daisuke Imanishi, MD, Hideki Tsushima, MD, Shinichiro Yoshida, MD, Jun Taguchi, MD, Tomoko Hata, MD, Masao Tomonaga, MD

Blood (2007) 110 (11): 2845.

https://doi.org/10.1182/blood.V110.11.2845.2845

Published: 2007

Journal Articles

Myeloperoxidase Increases Chemosensitivity of Leukemia Cells through the Generation of Reactive Oxigen and Nitrogen Species.

Yasushi Sawayama, Yasushi Miyazaki, Chizuko Tsutsumi, Koji Ando, Kazutaka Kuriyama, Masao Tomonaga

Blood (2006) 108 (11): 4506.

https://doi.org/10.1182/blood.V108.11.4506.4506

Published: 2006

NARROW

A First-in-Human Phase I Study of CTX-712 in Patients with Advanced, Relapsed or Refractory Malignant Tumors - Hematologic Malignancies Dose Escalation Cohort

Caspase-3 controls AML1-ETO–driven leukemogenesis via autophagy modulation in a ULK1-dependent manner

The AML-Associated FLT3-ITD Kinase Regulates Histone Modifications and Cytokine Signaling, Via Effects on PRMT5

Heat Shock Protein 90 Inhibitor NVP-AUY922 Has Potent Anti-Tumor Activity With Adult T-Cell Leukemia-Lymphoma Cells

Treatment of relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: the Nagasaki Transplant Group experience

Transcriptional Activity of MEF/ELF4 on the HDM2 Promoter Is Enhanced by the Mutation of the NPM1 Gene

Expression of 67-Kda Laminin Receptor (67LR) Relates to the Aggressiveness and Poor Prognosis of AML: Modulation of the Expression of GM-CSF Receptor by 67LR.

Expression of the 67-kDa Laminin Receptor Is Associated with Increased AML Cells through the Enhanced GM-CSF/Stat5 Signaling.

Myeloperoxidase Increases Chemosensitivity of Leukemia Cells through the Generation of Reactive Oxigen and Nitrogen Species.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only